AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian CancerTzu‐Ting Huang, Jung‐Min Lee|Cancer Research|2024Cited by 27
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancerJung‐Min Lee, Chien Chu Huang|Research Square|2025Cited by 0